SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Melania Trump is trending as users debate the legitimacy of the associated meme coin, with community members aggressively clashing over whether the project is a sophisticated grift or a viable asset. The discourse is heavily fueled by broader political polarization and skepticism surrounding the Trump family's various ventures in the cryptocurrency space.

WorldFinancial

WorldFinancial is seeing intense community speculation as investors closely watch for potential catalysts like bank charter approvals and upcoming legislative developments. Sentiment remains polarized, with many users highlighting a low circulating token supply as a primary driver for a possible rapid price movement, while others express skepticism over the project's long-term transparency.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is currently generating significant investor buzz as the community weighs its role in space exploration and mission-critical defense hardware against recent volatility and technical pullbacks. Traders are closely monitoring a potential inclusion in the Russell 2000 Index while debating whether the stock's recent price action represents a temporary accumulation phase or a deeper correction.

TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.

TOYO Co Ltd.

TOYO Co., Ltd

Toyo Co. is trending as investors show strong conviction in its upcoming financial updates and U.S. manufacturing expansion, despite recent volatility driven by short-selling activity and broader solar sector uncertainty. The community is focused on the company's strong fundamentals and profitability, with many traders accumulating shares ahead of anticipated analyst coverage and institutional interest.

BitGo Holdings, Inc. operates as a digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. It focuses on accelerating the transition of the financial system to a digital asset economy. The company was founded by Michael Belshe and Ben Davenport in 2013 and is headquartered in Sioux Falls, SD.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo is currently generating significant community debate, driven by a recent announcement that a Trump family-backed crypto firm received conditional approval for a national trust bank charter, which includes custody services that compete directly with BitGo's established infrastructure. While some investors view the company as an essential, regulated player poised to benefit from potential legislative tailwinds like the Clarity Act, others express deep skepticism due to recent lackluster earnings, concerns over stock manipulation, and persistent price volatility.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

TRUMP CRYPTO is facing intense scrutiny as community members debate allegations of it being a rug-pull scam, while supporters continue to frame it as a long-term play against perceived political sabotage. Discussions are heavily polarized, centering on the token's significant price decline and the broader controversy regarding Donald Trump's involvement in various crypto ventures.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending due to a definitive agreement for its acquisition by Argenx in an all-cash deal, a move that sparked significant momentum after the company's recent clinical milestones. The community is actively debating the implications of this exit for long-term shareholders while monitoring the stock's price action as it stabilizes near the acquisition offer level.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong community interest driven by the growth of Briumvi and high anticipation for its subcutaneous formulation, which has fueled persistent buyout speculation. Investors are closely watching for updates on commercial execution and potential strategic interest from larger biopharma players in light of positive market share momentum.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is trending as traders debate whether current price levels represent a prime accumulation opportunity or a signal of further downside risk. The community is actively discussing potential supply shocks from upcoming staking activities and network upgrades, while split sentiment persists regarding the project's long-term utility versus its recent technical stability.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors react to encouraging phase 2 results for Ivonescimab in triple-negative breast cancer, fueling community optimism about the drug's expanding potential across multiple indications. Despite ongoing debates regarding data quality and trial design compared to established industry standards, shareholders are closely watching for further clinical validation as they look toward future regulatory milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nebius Group is surging as investors aggressively squeeze short positions, fueled by community sentiment that the stock remains a high-growth AI infrastructure play despite warnings from prominent short sellers. Discussion is dominated by the stock's rapid recovery and the belief that ongoing institutional buying and strong earnings momentum will continue to drive it toward new highs.

Dan Ives Says Hyperscaler Earnings, Neoclouds Like CRWV, NBIS Show AI Has Entered Monetization Phase: 'That Was The Validation Sign Investors Needed'

NBIS surged on strong Q2 results, with revenue up 454% YoY and adjusted EBITDA swinging to $236M, plus contracted capacity raised to 5GW, while Michael Burry's disclosed short position fueled a retail-driven squeeze.

Why Is Nebius Stock Surging Friday?

Nebius Group (NBIS) stock surges 8% as Q2 revenue jumps 454% to $582.3M, driven by massive demand for its AI cloud capacity.read more...

Can South Wales Deployment Help Nebius Expand Its AI Cloud Footprint?

NBIS expands its U.K. AI footprint with NVIDIA-powered infrastructure at Vantage's Newport campus, supporting diverse AI workloads.

Equity

During an interview with CNBC, Ives said this shift from capital expenditure to monetization is an inflection point in the AI revolution.


Zacks Investment Ideas feature highlights: CoreWeave, Nebius and NVIDIA

CoreWeave and Nebius Group are riding explosive AI infrastructure demand, huge backlogs and expanding margins as NVIDIA's newest chips drive growth.

Michael Burry Says His Short Load Is 'Maybe Even More Aggressive' Than 2020 — But ‘Memesville’ Leader CoreWeave Is Off Limits

Burry believes CoreWeave’s limited float, retail popularity, and short-squeeze potential make it too dangerous to bet against.

Michael Burry Loads Up On QQQ Puts, Boosts MU Short As He Braces For ‘Larger Fall’ — Here’s What He Did To NVDA, PLTR And TSLA

‘The Big Short’ investor is cutting overall exposure and shifting his portfolio as a recent market rally pushes his short book into the red.

Neoclouds CRWV & NBIS Soar (Why they have room to run)

CoreWeave and Nebius Group's results illustrate that purpose-built AI infrastructure is the engine of the AI supercycle.

Nebius Surges 34% Post Q2: Will $40B Backlog Power Further Growth?

NBIS' Q2 revenues surge 454% as backlog tops $40B, boosting multi-year visibility while capacity expansion shapes its 2027 growth outlook.

CoreWeave's $35-$39B Capex Plan: Can AI Demand Justify the Spend?

CRWV raises 2026 capex to $35-$39B as surging AI demand, a $104.2B backlog and over $25B in new commitments support its rapid capacity buildout.

NBIS Q2 Earnings Call Puts 2027 Capacity and Pricing in Focus

Nebius keeps part of its 2027 capacity uncommitted as it targets premium pricing, expands power and uses customer prepayments to fund growth.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Extremely Bullish Sentiment

Buying

Holding

Selling or trimming

Watching from the sidelines

AI infrastructure stocks are under pressure this week - what have you been doing?

Stocktwits

Stocktwits Polls

Nebius Group N.V. 

Bullish investors are celebrating as a massive surge in price forces short sellers to cover their positions amidst high volatility.

Investors are actively debating the high-profile bearish stance of Michael Burry, frequently treating his market calls as a contrarian indicator.

Enthusiastic chatter surrounds the rapid expansion of AI infrastructure and hyperscaler revenue growth as key fundamental catalysts.

Intense disagreement persists between long-term growth believers and bears highlighting astronomical PE ratios and potential bubble risks.

Current Price	$277.68
Prev Close	$255.04
Open	$258.09
Dividend Yield	0.00%
50-Day Moving Average	$222.24
Beta	2.17
Avg. Volume	22.08M
PE Ratio	1,050.23

52-Week High	$299.86
52-Week Low	$62.01
Market Capitalization	$75.49B
EPS (Annual)	$0.3402
Price to Book	7.30
Revenue Per Employee	$343,357.10

Feed

News

Sentiment

Earnings

Fundamentals

Info